推荐
美文 健康

British teenager with life-threatening infection successfully treated with phage therapy

Isabelle Carnell-Holdaway is a British teenager with cystic fibrosis. When she was 15, Isabelle underwent a lung transplant at Great Ormond Street Hospital, and whilst recovering, developed a life-threatening, multi-drug resistant infection. Realizing that antibiotics were not going to work, doctors decided to try an experimental treatment in the form of genetically engineered viruses (known as bacteriophages) that infect and kill bacteria. The treatment was highly successful, and the details of the case study were published in the latest issue of the journal Nature Medicine. Design_Cells | Shutterstock Isabelle's mother Jo Holdaway described the treatment process, saying: We were at the point where there was no other hope, they said she wasn't going to leave the hospital and had less than 1 percent chance of survival.” Isabelle was given a ‘cocktail’ of bacteriophages that targeted and killed the rogue bacteria. Thanks to the innovative treatment, she is back to taking her regular medication and is learning how to drive. The treatment, known as phage therapy, has previously been investigated as a potential solution to antibiotic resistance. However, a large-scale roll out is unlikely to happen soon, as the treatment is still in the experimental stages and will need refinement, as well as large clinical trials, to prove that it is safe and effective. The practice of using bacteria-engulfing viruses as treatment of severe bacterial infections has been around for nearly a century. It has not been used widely or tried in large clinical trials yet because bacteriophages are highly specific in the bacteria they target and need to be generated on a case-by-case basis. This means they cannot be used in emergencies where broad-spectrum antibiotics need to be administered immediately before the cause of the infection is known. Unlike previous experiments, the researchers treating Isabelle used genetically modified phages which made them more effective than those occurring naturally. This is the first person who has been treated for a mycobacterium infection with phage therapy that we’re aware of.” Dr. Helen Fisher, Respiratory Paediatrician ‘Desperate for other options’ Following a lung transplant, Isabelle developed an infection within the healing wounds. This infection soon spread to her liver and the donated lung, causing her to spend the most part of the following year in the hospital. She was incredibly sick. She had fulminant [acute] liver failure... She was pretty much bed bound, wasn’t eating at all, we were having to feed her intravenously... Isabelle’s parents knew we were trying to work on this phage therapy, so when the time came that we had no other conventional therapies to use and ongoing signs of infection – they were desperate for other options.” Dr. Spencer, Senior Author Professor Graham Hatfull, a microbiologist at the University of Pittsburgh was sent samples of Isabelle’s infection along with samples of another infected patient. Professor Hatfull’s laboratory has a large collection of bacteriophages (over 15,000) that have never been used for therapeutic purposes. Professor Hatfull explained, “We were sent a few strains, from London, and set about testing whether the phages in our collection would be able to infect these particular bacterial strains.” In January 2018, the researchers found a single bacteriophage strain (which they named ‘Muddy’) that was able to kill the bacterium causing Isabelle’s infection. They took this strain and two others and genetically modified them to increase their efficacy against the infection. The experts believe that using more than one strain could help prevent the bacteria from mutating and becoming resistant to the bacteriophage, as they are being challenged by multiple phages at once. ‘A targeted strike’ The next step, which began in June 2018, involved the team giving Isabelle twice-daily infusions containing millions of genetically engineered bacteriophages. Within six weeks, the infection had disappeared from Isabelle’s liver completely. The team used a combination of the phages and antibiotics to treat the remaining infections in her skin. Professor Hatfull called antibiotics “blunt instruments” and said, “With phages it’s the opposite end of the spectrum. They’re very specific, it’s a targeted strike, you’re not going to affect the rest of the microbiome and they’re low toxicity because they don’t infect human cells.” However, “it’s a double-edged sword”, he said, “because they may target the strain infecting patient number one, but patient two or three, may have the same species of bacteria but the strain can vary to such an extent that it doesn’t work.” Jason Gill, a senior scientist at the center for phage technology at Texas A&M University in her statement said that it could be an option against antibiotic resistance, but won’t work for everyone: It’s probably going to turn out that the phages are going to be really effective for some conditions, and others they won’t work that well.” Despite this, the medical and scientific communities are inspired. Professor Martha Clokie, from the University of Leicester, said in a statement: I think that this work is enormously exciting. It shows how bacteriophages can be successfully developed as therapeutics even in very difficult circumstances where bacteria are resistant to many antibiotics and the bacteria are difficult to treat.” “I think it will pave the way for other such studies to help with getting the necessary trials carried out on bacteriophages so that they can be used more widely to treat humans,” he said. ‘An opportune time for basic researchers’ The new study is supported by several previous research papers which have explored the potential of phage therapy. For example, Kaitlyn Kortright from the Yale School of Medicine and colleagues recently published a review article in the journal Cell Host Microbes. The review, which was titled, “Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria”, examined the history of phage therapy research in Western countries. The researchers concluded the research, saying “phage therapy like any medical treatment, has benefits, costs, and limitations in usefulness that merit close scrutiny”. They finish by saying, “this is an opportune time for basic researchers, clinicians, and physicians to work together to address open questions through rigorous experiments in the laboratory, in vivo models, and clinical cases to reward phage therapy with the renewed interest and greater examination that it deserves”. Fernando Altamirano and colleagues from the School of Biological Sciences, Monash University say that now is the time for the “rebirth” of phage therapy as part of the “multidimensional strategies to combat antibiotic resistance”. In a recent review, published in in the journal Clinical Microbiology Reviews, the team writes that antibiotic resistance is one of the biggest public health problems today. The therapeutic use of bacteriophages, viruses that infect and kill bacteria, is well suited to be part of the multidimensional strategies to combat antibiotic resistance.” They explain that this concept was discovered almost a century ago and was overshadowed by the discovery of antibiotics. With rise of antibiotic resistance, there is soon to be a “rebirth” of these agents. Journal reference: Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. DOI:10.1038/s41591-019-0437-z.

相关文章

健康 2020-04-03
默克公司,一家领先的科技公司,今天宣布与瑞士的合同研究和服务提供商Solvias合作,提供Pyromat?系统,一种用于热原检测的新材料套件。该套件与默克公司热原检测产品组合中的其他产品一起,由两家公
健康 2020-04-03
根据疾病控制与预防中心(CDC)的数据,2007年至2017年间,美国有50多万人死于药物过量。越来越多的死亡涉及主要来自中国的合成类阿片。这种流行病非常严重,每天大约有130名美国人死于与阿片类药物
健康 2020-04-03
IsabelleCarnell-HoldawayisaBritishteenagerwithcysticfibrosis.Whenshewas15,Isabelleunderwentalungtran
健康 2020-04-03
英国女王沙基拉·塔加拉蒂南在本周出版的《公共科学图书馆医学》杂志上发表的一项新研究表明,怀孕期间地中海式饮食并不能降低母婴并发症的风险,但可以减少怀孕期间体重增加和妊娠期糖尿病的风险。英国伦敦玛丽大学
健康 2020-04-03
人工智能驱动的药物设计和开发公司CloudPharmaceuticals,Inc.今天宣布,他们已与葛兰素史克公司(GSK)开展药物发现合作。云将设计新的小分子制剂,以GSK指定的目标。云将使用其专有
健康 2020-04-03
据本周发表的最新研究显示,接受雄激素剥夺疗法(ADT)的前列腺癌幸存者患慢性疾病的风险更高,这是一种常用于阻止男性激素释放的疗法。在一项分析2003年至2014年约3700名前列腺癌幸存者的药物记录的
健康 2020-04-03
生物城,一个开创性的生命科学孵化器和商业团体,今天宣布投资于InCus的业绩,进一步巩固了他们作为一个有前途的投资家的地位。图为L-R:斯图亚特·斯宾塞,查伦伍德会计师事务所。ImeldaJuniar
健康 2020-04-03
一位病人的死亡改变了莉莉娅·塞万提斯医生的职业生涯。塞万提斯说,这名患者是一名来自墨西哥的肾衰竭妇女,她反复到急诊室就诊超过三年。当时,她的心脏不止一次停止跳动,她的肋骨因心肺复苏而断裂。这名妇女最终
健康 2020-04-03
无创装置可使肾病、充血性心力衰竭或脱水患者受益。对于需要透析的肾衰竭患者来说,以正确的速度排出液体并在正确的时间停止是至关重要的。这通常需要猜测需要排出多少水,并仔细监测患者血压是否突然下降。目前还没
健康 2020-04-03
脊髓损伤(SCI)中的瘫痪损伤往往是由对损伤的狂热免疫反应引起的。NIBIB资助的工程师们已经开发出纳米颗粒,可以将免疫细胞从脊髓中吸引出来,使老鼠的脊髓功能得以恢复。就像在大脑中一样,脊髓也有血脑屏
健康 2020-04-03
高血糖或高血糖水平在急性缺血性卒中患者中很常见,与正常血糖水平相比,高血糖与更差的预后相关。动物研究也指出了高血糖对加重中风损伤的作用。中风专家们讨论了急性缺血性中风后强化葡萄糖管理是否会带来更好的结
健康 2020-04-03
一项新的研究报告成功地免疫了迄今为止不可战胜的一种与艾滋病毒相关的实验室病毒(sivmac239)和另一种艰难的病毒株的“死亡之星”菌株。这一新方法还实现了单剂量的长期保护,表明基因疗法可以基于一种改
健康 2020-04-03
7月13日,全国家庭商业场所奖在温布利体育场庆祝了他们的10周年纪念日,当地的医疗设备制造商BedfontScientificLtd.在温布利体育场获得了有史以来第一个全国性的技术和创新类商业奖。相关
健康 2020-04-03
你在人群面前说话会感到焦虑吗?你会觉得喉咙里有只青蛙吗?新的研究表明,压力可能是这种声音问题的罪魁祸首。在哥伦比亚密苏里大学的研究人员的一项新研究中,他们想确定压力和声音障碍,特别是肌肉紧张性发音困难
健康 2020-04-03
将医疗目标定位于生病的身体部位和药物本身一样古老。创可贴放在有皮的膝盖上。滴落物进入眼睛发痒。断了的胳膊变成了石膏。但通常我们的病是在身体内部,不容易触及。在这种情况下,可能需要进行手术或化疗等治疗。
健康 2020-04-03
烟草是全球主要的潜在单一死因。2016年,烟草使用导致710多万人死亡,主要与肺癌、心脏病、癌症和中风有关。每年5月31日,人们和组织都在世界无烟日庆祝,强调与烟草使用有关的健康和其他风险,并倡导有效
健康 2020-04-03
免疫疗法是对抗癌症的新武器,在现有研究的基础上,马萨诸塞州总医院的一个研究小组设计了一种方法,使免疫疗法在一种致命的、常见的脑肿瘤中更有效,这种肿瘤被称为胶质母细胞瘤。他们的研究题为“分泌咬合物的ca
健康 2020-04-03
马萨诸塞大学阿默斯特分校和马萨诸塞大学医学院的研究人员是全国十几个机构的科学家之一,这些机构将组建司法界阿片类创新网络(JCOIN),这是一项雄心勃勃的、1.55亿美元的努力,旨在改善阿片类成瘾。国家
健康 2020-04-03
一项调查青少年头发中皮质醇水平的新研究的作者说,一缕头发可能有一天会帮助诊断抑郁症,并努力监测治疗效果。研究人员寻找了头发中压力激素皮质醇浓度与青少年抑郁症状之间的潜在关系,发现了一种令人惊讶的联系。
健康 2020-03-10
一组科学家在老鼠身上设计和测试了一种新的、有希望的治疗拉福拉病(LD)的治疗策略,这种疾病是儿童癫痫的致命形式。这种新型药物被称为抗体酶融合(AEF),是治疗LD的一流疗法,也是治疗其他类型聚集性神经
健康 2020-03-10
来自加州理工大学工程和应用科学部的研究人员已经开发出微型机器人,可以很快将药物输送到不需要手术就很难到达的身体部位。此外,微型机器人在体内的活动可以通过传感器从体外进行监控。他们的研究题为“一个由光声
健康 2020-03-10
现场服务公司探索自动化的活动工业IT和自动化专家诺富特英国和爱尔兰将在伦敦Excel的现场服务管理博览会上展出。该活动于2018年6月19日至21日举行,汇集了服务管理、物流和运营各方面的专业人士。诺
健康 2020-03-10
加州大学欧文医学院的研究人员与加州大学旧金山分校和西北大学的科学家合作,对人类乳腺上皮细胞进行了分析,确定了三个不同的新上皮细胞群。这些细胞群的发现有助于了解乳腺癌的起源,并提高早期癌症的检出率,减缓
健康 2020-03-10
安大略省烟草研究机构多伦多大学的研究人员称,过去16年里,安大略省收入最高的电影中有一半以上都是以吸烟为特色的,而且这些电影中的大多数都被评为青少年可以接受的。自2002年以来,成人伴奏(AA)或14
健康 2020-03-10
粪便微生物群移植(fmt),或将粪便从健康的供体转移到患者身上,已被发现在逆转成人严重的艰难梭菌腹泻感染方面非常有效。艰难梭菌病已知与肠道微生物群改变有关,移植粪便似乎恢复了正常的平衡。口蹄疫对艰难梭
健康 2020-03-10
dolutegravir是治疗艾滋病毒感染的首选药物,但最近它与怀孕早期接受药物治疗的母亲所生婴儿神经管缺陷风险增加6至9倍有关。贝勒医学院的研究人员怀疑叶酸(维生素B9)可能是Dolutegravi
健康 2020-03-10
能源部橡树岭国家实验室目前正在生产锕-227(AC-227),以满足美国能源部同位素计划与拜耳公司签订的10年合同对高效癌症药物的预期需求。Xofigo(镭RA-223二氯化物)用于治疗对激素或降低睾
健康 2020-03-10
圣裘德儿童研究医院的一份报告将BRCA2基因的遗传突变与儿童和青少年患非霍奇金淋巴瘤的风险增加联系起来。这项工作作为一个先进的在线出版物今天在牙买加肿瘤学。“众所周知,BRCA基因家族与乳腺癌、卵巢癌
健康 2020-03-10
在美国,至少有1500万人因出汗过多或多汗症而生活质量下降。美国皮肤病学会的皮肤病学家说,许多治疗方法都是可行的,然而有一半的患者会推迟治疗10年或更长时间。我们都会出汗到一定程度。然而,有些人几年来